Antipsychotics, Metabolic Adverse Effects, and Cognitive Function in Schizophrenia

Cognitive impairment is a core symptom domain of schizophrenia. The effect of antipsychotics, the cornerstone of treatment in schizophrenia, on this domain is not fully clear. There is some evidence suggesting that antipsychotics may partially improve cognitive function, and that this improvement ma...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Nicole E. MacKenzie, Chantel Kowalchuk, Sri Mahavir Agarwal, Kenya A. Costa-Dookhan, Fernando Caravaggio, Philip Gerretsen, Araba Chintoh, Gary J. Remington, Valerie H. Taylor, Daniel J. Müeller, Ariel Graff-Guerrero, Margaret K. Hahn
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2018-12-01
Collection:Frontiers in Psychiatry
Sujets:
schizophrenia
antipsychotics
metabolic syndrome
cognitive dysfunction
mechanism
inter-relationship
Accès en ligne:https://www.frontiersin.org/article/10.3389/fpsyt.2018.00622/full
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires